Score Breakdown
Dilution Forecast
Market Data
Source-Backed Evidence Depth
This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.
| Field | Current Value | Basis |
|---|---|---|
| DilutionScore | 37/100 | DilutionWatch score record |
| Shares Outstanding | 1.02M | Verified float table or market cache |
| Public Float | Not available | Verified float table or market cache |
| Market Cap | $32.27M | Market data cache |
| Cash Runway | 47.7 months | DilutionWatch score inputs |
| Shelf Capacity | None in current score inputs | SEC-derived dilution fields |
| ATM Capacity | None in current score inputs | SEC-derived dilution fields |
| Outstanding Warrants | None in current score inputs | SEC-derived dilution fields |
Recent source-backed SEC insight records available on this page: 5.
Recent SEC source mix: 4 3, XBRL 2.
The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.
Institutional Holdings
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Recent SEC Activity
Recent News
Factual QNCX Dilution Snapshot
Quince Therapeutics, Inc. (QNCX) has a DilutionScore of 37/100, rated Medium dilution risk. Score date: October 13, 2026.
- Recent SEC activity tracked for QNCX: xbrl on 2026-04-10; 4 on 2026-01-23; 4 on 2026-01-23.
- Score coverage note: Float Risk is excluded because public-float data is unavailable.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
DilutionScore History — Last 90 Days
QNCX's DilutionScore is currently 37/100 (Medium risk), with 6 score changes tracked over 89 days. The score improved from 34/100 (Medium risk).
| Period | Score | Risk Level | Duration |
|---|---|---|---|
| Oct 08 – Oct 13, 2026 | 37/100 | MEDIUM | 6 days |
| Oct 01 – Oct 07, 2026 | 34/100 | MEDIUM | 7 days |
| Sep 28 – Sep 30, 2026 | 30/100 | MEDIUM | 3 days |
| Aug 22 – Sep 27, 2026 | 32/100 | MEDIUM | 37 days |
| Aug 14 – Aug 21, 2026 | 56/100 | HIGH | 7 days |
| Jul 17 – Aug 13, 2026 | 52/100 | HIGH | 28 days |
| Jul 16, 2026 | 53/100 | HIGH | 1 day |
Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.
Related Stocks — MEDIUM Risk
Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:
Score Coverage Note
- Float Risk is excluded because public-float data is unavailable.
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.